e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Cell and molecular biology of pulmonary hypertension and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD
B. Beghé, E. Bazzan, F. Calabrese, R. Zuin, G. Turato, S. Baraldo, C. Regorda, C. Schiraldi, F. Rea, P. Maestrelli, L. M. Fabbri, M. Saetta (Padova, Italy)
Source:
Annual Congress 2003 - Cell and molecular biology of pulmonary hypertension and COPD
Session:
Cell and molecular biology of pulmonary hypertension and COPD
Session type:
Oral Presentation
Number:
2538
Disease area:
Airway diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Beghé, E. Bazzan, F. Calabrese, R. Zuin, G. Turato, S. Baraldo, C. Regorda, C. Schiraldi, F. Rea, P. Maestrelli, L. M. Fabbri, M. Saetta (Padova, Italy). Expression of TGFβ-1 and TGFβ-1RII in pulmonary arteries of patients with severe COPD. Eur Respir J 2003; 22: Suppl. 45, 2538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Microvascular changes in COPD patients with severe pulmonary hypertension
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD
Source: Eur Respir J 2002; 19: 632-638
Year: 2002
Changes of pulmonary artery distensibility in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
Versican and collagen-III expression in bronchial and pulmonary muscular arteries in COPD patients
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
The effectiveness of pulmonary rehabilitation in Russian patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease
Year: 2009
Pulmonary artery hypertension and severity of airflow limitation in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
Morphology of pulmonary tissue in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 456s
Year: 2003
Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
microRNAs are deregulated in pulmonary arteries from COPD patients
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
Clinical and investigational profiles of elevated pulmonary artery pressures in patients with stable chronic obstructive pulmonary diseases
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
Morphometric characteristic of pulmonary artery in COPD and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008
Effects of Valsartan on pulmonary hemodynamics in patients with chronic obstructive pulmonary disease (COPD) and secondary pulmonary hypertension
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Effects of pulmonary rehabilitation on systemic and pulmonary inflammation in COPD patients
Source: Annual Congress 2010 - Exercise in COPD
Year: 2010
A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Comparison of CT scan-measured pulmonary artery to aorta ratio of combined pulmonary fibrosis and emphysema (CPFE) and COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Effects of Diltiazem on pulmonary hemodynamics and right heart function in patients with chronic obstructive pulmonary disease (COPD)>
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
TGF-β1 type II receptor (TGF-βRII) expression in pulmonary arteries of patients with severe COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 96s
Year: 2005
Role of Rho-kinase pathway in et-1-induced vasoconstriction in pulmonary artery of chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept